Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc (AMRX) Option Chain
As of September 25, 2026, Amneal Pharmaceuticals Inc is trading at $19.77, a -0.18% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 59.4%. IV Rank is 37%.
Read more
Tracking the AMRX option chain helps you see every strike and expiry on Amneal Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Amneal Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AMRX options activity at a glance. Use our scanner to monitor the AMRX option chain in real time and filter for the AMRX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AMRX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the AMRX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where AMRX stock options are being actively traded and where they are not.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas.
It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Amneal Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen AMRX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of AMRX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile20.63% Subdued
- Market cap (M$)6,314
- 52 weeks high-6.66%
- 52 weeks low106.80%
- Analyst recommendationStrong Buy
1.12 - Target price$22.71
14.87% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-10-29
- P/E41.26
- Future P/E16.59
- EPS (ttm)0.48
- EPS growth next 5 years20.50%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 2.88 | 0 | 0 | 0.13 | 4.77 | 3.00 | 6.80 | 15.00 | -24.13 | — | 2.15 | 0.00 | 2.15 | 0 | 0 | 97.12 |
| 20.94 | 27 | 1 | 0.13 | 2.27 | 1.10 | 3.70 | 17.50 | -11.48 | — | 2.00 | 0.00 | 2.00 | 1 | 77 | 79.06 |
| 55.42 | 136 | 19 | 2.78 | 0.00 | 0.55 | 5.00 | 20.00 | +1.16 | 0.15 | 2.85 | 0.23 | 1.27 | 0 | 1 | 44.58 |
| 83.38 | 575 | 18 | 0.15 | 0.00 | — | 0.15 | 22.50 | +13.81 | 1.35 | 3.20 | 2.73 | -0.46 | 0 | 25 | 16.62 |
| 95.68 | 0 | 0 | 2.00 | 0.00 | — | 2.00 | 25.00 | +26.45 | 4.10 | 7.20 | 5.23 | 0.42 | 0 | 0 | 4.32 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full AMRX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→